Gautam Patel Exercises Options at Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, May 10, 2022

SEC Form 4 · No Market Transaction

Option Exercise

Derivative exercise — no open market transaction.

Reporting Owner

Gautam Patel

Director

TXN 2022-05-09 · FILED 2022-05-10

Equity Position 13.2M sh 13,146,217 → 13,181,623

Equity Change +0.3% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Amneal Pharmaceuticals Inc

AMRX CIK 0001723128

Reporting Owner

Name	Relationship
Gautam Patel CIK 0001738054	Director

Gautam Patel at Amneal Pharmaceuticals Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at Amneal Pharmaceuticals Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Class A Common StockF1	2022-05-08	M - Exercise	35,406 A		—	294,190	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Restricted Stock UnitsF1 F3 F3		2022-05-08	M - Exercise	35,406 D	$0.00		35,406 Class A Common Stock	Direct
Restricted Stock UnitsF1 F4 F4		2022-05-09	A - Award/Grant	80,128 A	$0.00		80,128 Class A Common Stock	Direct

Non-Derivative Holdings

Title	Shares Held	Ownership
Class A Common StockF2	12,887,433	Indirect

Footnotes (4)

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Show more
F2: By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Show more
F3: On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022. Show more
F4: Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 6 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Amneal Pharmaceuticals Inc

GET /v1/forms/4/0001209191-22-028166 API docs